Your browser doesn't support javascript.
loading
Immune deficiency, autoimmune disease and intellectual disability: A pleiotropic disorder caused by biallelic variants in the TPP2 gene.
Atallah, Isis; Quinodoz, Mathieu; Campos-Xavier, Belinda; Peter, Virginie G; Fouriki, Athina; Bonvin, Christophe; Bottani, Armand; Kumps, Camille; Angelini, Federica; Bellutti Enders, Felicitas; Christen-Zaech, Stéphanie; Rizzi, Mattia; Renella, Raffaele; Beck-Popovic, Maja; Poloni, Claudia; Frossard, Valérie; Blouin, Jean-Louis; Rivolta, Carlo; Riccio, Orbicia; Candotti, Fabio; Hofer, Michael; Unger, Sheila; Superti-Furga, Andrea.
Afiliação
  • Atallah I; Division of Genetic Medicine, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
  • Quinodoz M; Institute of Molecular and Clinical Ophthalmology Basel (IOB), Basel, Switzerland.
  • Campos-Xavier B; Department of Ophthalmology, University of Basel, Basel, Switzerland.
  • Peter VG; Department of Genetics and Genome Biology, University of Leicester, Leicester, UK.
  • Fouriki A; Division of Genetic Medicine, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
  • Bonvin C; Institute of Molecular and Clinical Ophthalmology Basel (IOB), Basel, Switzerland.
  • Bottani A; Department of Ophthalmology, University of Basel, Basel, Switzerland.
  • Kumps C; Department of Genetics and Genome Biology, University of Leicester, Leicester, UK.
  • Angelini F; Pediatric Immunology Unit, Division of Pediatrics, Lausanne University Hospital, Lausanne, Switzerland.
  • Bellutti Enders F; Division of Neurology, Lausanne University Hospital, Lausanne, Switzerland.
  • Christen-Zaech S; Division of Genetic Medicine, Geneva University Hospitals, Geneva, Switzerland.
  • Rizzi M; Division of Genetic Medicine, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
  • Renella R; Pediatric Immunology Unit, Division of Pediatrics, Lausanne University Hospital, Lausanne, Switzerland.
  • Beck-Popovic M; Pediatric Immunology Unit, Division of Pediatrics, Lausanne University Hospital, Lausanne, Switzerland.
  • Poloni C; Pediatric Dermatology Unit, Lausanne University Hospital, Lausanne, Switzerland.
  • Frossard V; Pediatric Hemato-Oncology Unit, Lausanne University Hospital, Lausanne, Switzerland.
  • Blouin JL; Pediatric Hemato-Oncology Unit, Lausanne University Hospital, Lausanne, Switzerland.
  • Rivolta C; Pediatric Hemato-Oncology Unit, Lausanne University Hospital, Lausanne, Switzerland.
  • Riccio O; Pediatric Neurology Unit, Sion Hospital, Sion, Switzerland.
  • Candotti F; Hemato-Oncology Unit, Sion Hospital, Sion, Switzerland.
  • Hofer M; Division of Genetic Medicine, Geneva University Hospitals, Geneva, Switzerland.
  • Unger S; Institute of Molecular and Clinical Ophthalmology Basel (IOB), Basel, Switzerland.
  • Superti-Furga A; Department of Ophthalmology, University of Basel, Basel, Switzerland.
Clin Genet ; 99(6): 780-788, 2021 06.
Article em En | MEDLINE | ID: mdl-33586135
ABSTRACT
Four individuals from two families presented with a multisystemic condition of suspected genetic origin that was diagnosed only after genome analysis. The main phenotypic features were immune system dysregulation (severe immunodeficiency with autoimmunity) and intellectual disability. The four individuals were found to be homozygous for a 4.4 Kb deletion removing exons 20-23 (NM_003291.4) of the TPP2 gene, predicting a frameshift with premature termination of the protein. The deletion was located on a shared chromosome 13 haplotype indicating a Swiss founder mutation. Tripeptidyl peptidase 2 (TPP2) is a protease involved in HLA/antigen complex processing and amino acid homeostasis. Biallelic variants in TPP2 have been described in 10 individuals with variable features including immune deficiency, autoimmune cytopenias, and intellectual disability or chronic sterile brain inflammation mimicking multiple sclerosis. Our observations further delineate this severe condition not yet included in the OMIM catalog. Timely recognition of TPP2 deficiency is crucial since (1) immune surveillance is needed and hematopoietic stem cell transplantation may be necessary, and (2) for provision of genetic counselling. Additionally, enzyme replacement therapy, as already established for TPP1 deficiency, might be an option in the future.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Autoimunes / Serina Endopeptidases / Mutação da Fase de Leitura / Dipeptidil Peptidases e Tripeptidil Peptidases / Aminopeptidases / Síndromes de Imunodeficiência Tipo de estudo: Prognostic_studies Limite: Adult / Child / Child, preschool / Female / Humans / Male Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Autoimunes / Serina Endopeptidases / Mutação da Fase de Leitura / Dipeptidil Peptidases e Tripeptidil Peptidases / Aminopeptidases / Síndromes de Imunodeficiência Tipo de estudo: Prognostic_studies Limite: Adult / Child / Child, preschool / Female / Humans / Male Idioma: En Ano de publicação: 2021 Tipo de documento: Article